UGR
  |
> >
PSYBAM Rsearch Group: Psychiatry, Biology and Environment
(Ref. CTS-628)
28
mayo
2026
mayo 2026
<- ->
L M X J V S D
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Producción científica


Buscar por:

Lista

Publicación
I. Nazareth and M. King-King,  "The health of people classified as lesbian, gay and bisexual attending family practitioners in London: A controlled study",  BMC Public Health, vol.6 , 127-127, 2006
M.J. Arranz Calderón "THE HIGH ACITIVITY VAL ALLELE OF THE COMT GENE PREDICTS GREATER COGNITIVE DETERIORATION IN PATIENTS WITH PSYCHOSIS",  Psychiatric Genetics, vol.16 , 213-216, 2006
M.J. Arranz Calderón "THE HIGH ACITIVITY VAL ALLELE OF THE COMT GENE PREDICTS GREATER COGNITIVE DETERIORATION IN PATIENTS WITH PSYCHOSIS",  PSYCHIATRIC GENETICS, vol.16 , 213-216, 2006
J.C. Leza Cerro, J. Caso , I. Lizasoain , P. Lorenzo and M. Moro ,  "THE ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN STRESS-INDUCED WORSENING OF CEREBRAL ISCHEMIA IN RATS.",  NEUROSCIENCE , 59-69, 2006
J.C. Leza Cerro, J. Caso-, I. Lizasoain-, P. Lorenzo- and M. Moro-,  "THE ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN STRESS-INDUCED WORSENING OF CEREBRAL ISCHEMIA IN RATS.",  Neuroscience , 59-69, 2006
M. Rivera Sánchez, B. Gutierrez Martinez, E. Molina Rivas, F. Torres-González , J.A. Bellón , B. Moreno-Küstner , J.A. Lorente Acosta and J. Cervilla Ballesteros,  "THE S/S GENOTYPE AT THE 5HTTLPR POLYMORPHISM INCREASES RISK FOR DEPRESSION IN A PRIMARY CARE SAMPLE.",  AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, vol.141B , 739-739, 2006
M. Rivera Sánchez, B. Gutierrez Martinez, E. Molina-Rivas, F. Torres-González-, J.A. Bellón-, B. Moreno-Küstner-, J.A. Lorente Acosta and J. Cervilla Ballesteros,  "THE S/S GENOTYPE AT THE 5HTTLPR POLYMORPHISM INCREASES RISK FOR DEPRESSION IN A PRIMARY CARE SAMPLE.",  American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, vol.141B , 739-739, 2006
J.M. Haro Abad "THE SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOME) STUDY: IMPLICATIONS FOR THE TREATMENT OF SCHIZOPHRENIA",  Drugs , 293-301, 2006

Última actualización del SICA: 25/03/2026

Desarrollado por: